Correlation Between Phoenix Biotech and Marblegate Acquisition

Can any of the company-specific risk be diversified away by investing in both Phoenix Biotech and Marblegate Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phoenix Biotech and Marblegate Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Phoenix Biotech Acquisition and Marblegate Acquisition Corp, you can compare the effects of market volatilities on Phoenix Biotech and Marblegate Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phoenix Biotech with a short position of Marblegate Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phoenix Biotech and Marblegate Acquisition.

Diversification Opportunities for Phoenix Biotech and Marblegate Acquisition

0.0

Correlation Coefficient

Phoenix Biotech  Marblegate Acquisition

Pay attention - limited upside

The 3 months correlation between Phoenix and Marblegate is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Phoenix Biotech Acquisition and Marblegate Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marblegate Acquisition and Phoenix Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phoenix Biotech Acquisition are associated (or correlated) with Marblegate Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marblegate Acquisition has no effect on the direction of Phoenix Biotech i.e., Phoenix Biotech and Marblegate Acquisition go up and down completely randomly.

Pair Corralation between Phoenix Biotech and Marblegate Acquisition

If you would invest  3.20  in Marblegate Acquisition Corp on December 5, 2024 and sell it today you would earn a total of  3.90  from holding Marblegate Acquisition Corp or generate 121.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Phoenix Biotech Acquisition  vs.  Marblegate Acquisition Corp

Phoenix Biotech Acqu

Risk-Adjusted Performance

Very Weak

Over the last 90 days Phoenix Biotech Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Phoenix Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Marblegate Acquisition

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Marblegate Acquisition Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, Marblegate Acquisition showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Phoenix Biotech and Marblegate Acquisition

The main advantage of trading using opposite Phoenix Biotech and Marblegate Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phoenix Biotech position performs unexpectedly, Marblegate Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marblegate Acquisition will offset losses from the drop in Marblegate Acquisition's long position.

The idea behind Phoenix Biotech Acquisition and Marblegate Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.